Solvay to sell pharmaceuticals business to Abbott for €4.5 billion

Solvay SA has become the latest European company to alter its business strategy with a decision to sell its pharmaceutical business to Abbott Laboratories for €4.5 billion. It will reinvest the proceeds in chemicals and plastics.